Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the Globe

Rashedi, Alexandra S.; Roo, Saskia F de; Ataman, Lauren; Edmonds, Maxwell E; Silva, Adelino Amaral; Scarella, Aníbal; Horbaczewska, Anna; Anazodo, Antoinette; Arvas, Ayşe; Carvalho, Bruno Ramalho de; Sartório, Cássio; Beerendonk, C.C.M.; Díaz-García, César; Suh, Chang Suk; Melo, Claudia de O.; Andersen, Claus Yding; Motta, E.L.A.; Greenblatt, Ellen; Moer, Ellen Van; Zand, Elnaz; Reis, Fernando M.; Sánchez, Flor; Terrado, Guillermo; Rodrigues, Jhenifer Kliemchen; Silva, João Marcos de Meneses e; Smitz, Johan; Medrano, José V.; Lee, Jung Ryeol; Winkler-Crepaz, Katharina; Smith, Kristin; Silva, Lígia Helena Ferreira Melo E; Wildt, L.; Salama, Mahmoud; Andrés, María del Mar; Bourlon, María Teresa; Vega, Mario; Chehin, Maurício B.; Vos, M. De; Khrouf, Mohamed; Suzuki, Nao; Azmy, Osama; Fontoura, Paula; Campos-Júnior, Paulo Henrique Almeida; Mallmann, Peter; Azambuja, Ricardo; Marinho, Ricardo Mello; Anderson, Richard A.; Jach, Robert; Antunes, Roberto de Azevedo; Mitchell, Rod; Fathi, Rouhollah; Adiga, Satish Kumar; Takae, Seido; Kim, Seok Hyun; Romero, Sergio; Grieco, Silvana Chedid; Shaulov, Talya; Furui, Tatsuro; Almeida‐Santos, Teresa; Nelen, W.L.D.M.; Jayasinghe, Yasmin; Sugishita, Yodo; Woodruff, Teresa K.

doi:10.1200/jgo.2017.009944

Cited by 30 publications

(30 citation statements)

References 9 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, more and more women around the world are being referred for MEF over time, as has been suggested in a number of recent global assessments ( Rashedi et al, 2018a , Rashedi et al, 2018b , Salama and Woodruff, 2017 ). Thus, the time will come when MEF is viewed as both a rational and ethical measure for women needing fertility preservation, especially as cancer survival rates improve around the globe ( Pereira and Schattman, 2017 ).…”

Section: Discussionmentioning

confidence: 98%

Medical egg freezing: How cost and lack of insurance cover impact women and their families

Inhorn¹,

Birenbaum‐Carmeli²,

Westphal³

et al. 2018

Reproductive Biomedicine & Society Online

View full text Add to dashboard Cite

Medical egg freezing (MEF) is being recommended increasingly for women at risk of losing their reproductive ability due to cancer chemotherapy or other fertility-threatening medical conditions. This first, binational, ethnographic study of women who had undergone MEF sought to explore women's experiences under two different funding systems: (i) the USA, where the cost of MEF is rarely covered by private or state health insurance; and (ii) Israel, where the cost of MEF is covered by national health insurance. Women were recruited from four American and two Israeli in-vitro fertilization clinics where MEF is offered. In-depth, semi-structured interviews were conducted with 45 women (33 Americans, 12 Israelis) who had completed at least one cycle of MEF. All of the Israeli women had cancer diagnoses, but were not faced with the additional burden of funding an MEF cycle. In marked contrast, the American women – 23 with cancer diagnoses and 10 with other fertility-threatening medical conditions – struggled, along with their families, to ‘piece together’ MEF funding, which added significant financial pressure to an already stressful situation. Given the high priority that both American and Israeli women in this study placed on survival and future motherhood, it is suggested that insurance funding for MEF should be mandated in the USA, as it is in Israel. This article concludes by describing new state legislative efforts in this regard.

show abstract

Section: Discussionmentioning

confidence: 98%

Medical egg freezing: How cost and lack of insurance cover impact women and their families

Inhorn¹,

Birenbaum‐Carmeli²,

Westphal³

et al. 2018

Reproductive Biomedicine & Society Online

View full text Add to dashboard Cite

show abstract

“…Stem cells reproductive technologies may be attempted in research settings. If fertility preservation options are rejected, contraindicated, infeasible, unavailable, or unsuccessful, adoption and thirdparty reproduction (egg donation, embryo donation, and surrogacy) can be offered as family building alternatives [252][253][254]. In such situations, patient navigators can play a crucial rule in reassuring and guiding patients during counseling.…”

Section: Current Multidisciplinary Challenges and Future Trends Of Fementioning

confidence: 99%

Preserving fertility in female patients with hematological malignancies: a multidisciplinary oncofertility approach

2019

View full text Add to dashboard Cite

Oncofertility is a new interdisciplinary field at the intersection of oncology and reproductive medicine that expands fertility options for young cancer patients. The most common forms of hematological malignancies that occur in girls and young women and therefore necessitate oncofertility care are acute lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin's lymphoma, and Hodgkin's lymphoma. Aggressive gonadotoxic anticancer regimens including alkylating chemotherapy and total body irradiation are used often in treating girls and young women with hematological malignancies. The risks of gonadotoxicity and subsequent iatrogenic premature ovarian insufficiency and fertility loss depend mainly on the type and stage of the disease, dose of anticancer therapy as well as the age of the patient at the beginning of treatment. To avoid or at least mitigate the devastating complications of anticancer therapy-induced gonadotoxicity, effective and comprehensive strategies that integrate different options for preserving and restoring fertility ranging from established to experimental strategies should be offered before, during, and after chemotherapy or radiotherapy. A multidisciplinary approach that involves strong coordination and collaboration between hemato-oncologists, gynecologists, reproductive biologists, research scientists, and patient navigators is essential to guarantee high standard of care.

show abstract

“…Within Australia, all third party parenting is legally permissible if performed altruistically. It is illegal to financially renumerate any third party parenting arrangement under Australian law . However, adoption, surrogacy and gamete donation are rarely discussed with paediatric and adolescent patients and are more commonly mentioned with adult oncofertility patients .…”

Section: Resultsmentioning

confidence: 99%

“…38 While testicular tissue cryopreservation is being undertaken in Australia, 39 Australian law. 40,41 However, adoption, surrogacy and gamete donation are rarely discussed with paediatric and adolescent patients and are more commonly mentioned with adult oncofertility patients. 42 Third party parenting options are not available in all fertility clinics.…”

Section: Male Fertility Preservationmentioning

confidence: 99%

Fertility preservation in oncology patients: A literature review examining current fertility preservation techniques and access to oncofertility services in Australia

Robson

Phua

Howard

et al. 2019

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

Background In Australia, between the years 2010 and 2014, over 4500 adolescents and young adults (15–25 years old) were diagnosed with cancer. Treatment regimens are often gonadotoxic and are well known to induce ovarian and testicular failure. Oncofertility is an emerging discipline in obstetrics and gynaecology which seeks to preserve and restore the reproductive future of cancer patients. Aim To perform a systematic literature review to assess the current fertility preservation techniques available to patients and examine access and uptake of fertility preservation in Australia. Materials and Methods Electronic databases, including Medline, Cochrane Review, SCOPUS and CINHAL, were searched for peer‐reviewed publications and national guidelines examining oncofertility practices from 2008 to July 2018. Three hundred and seventy‐five articles were initially screened, with 158 articles for full text review and an additional five clinical guidelines were identified. Results There is a paucity of Australian data on oncofertility with <50% of data included for analysis reflecting the Australian experience. The majority of primary research included retrospective papers with small cohort numbers. Key areas addressed included live birth outcomes, uptake of services and patient and physician perspectives on fertility preservation. Few articles sought to examine the positive and negative side effects of fertility preservation in oncology, social challenges of oncofertility and access to services worldwide. Conclusion Oncofertility is an emerging discipline which seeks to provide safe, efficient and effective fertility preservation options for young adults and adolescents diagnosed with cancer. A multi‐disciplinary approach with collaborative communication with oncologists is key to providing this service within Australia.

show abstract

Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the Globe

Cited by 30 publications

References 9 publications

Medical egg freezing: How cost and lack of insurance cover impact women and their families

Medical egg freezing: How cost and lack of insurance cover impact women and their families

Preserving fertility in female patients with hematological malignancies: a multidisciplinary oncofertility approach

Fertility preservation in oncology patients: A literature review examining current fertility preservation techniques and access to oncofertility services in Australia

Contact Info

Product

Resources

About